Concepedia

Huw D. Thomas

HD

Statistics

Publications

58

Citations

9.3K

H-Index

35

Active since

1986

Affiliations

Newcastle University(Current)

Newcastle upon Tyne Hospitals NHS Foundation Trust

Pfizer (United States)

Freeman Hospital

Cancer Research UK

Huw D. Thomas is an author at Newcastle University specializing in oncology, medicine, and pharmacology.

Publications per year

1986–2023

58

Publications

58

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations

, , +12

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

Christopher Calabrese, Robert J. Almassy, Stephen Barton et al. · JNCI Journal of the National Cancer Institute · 2004 · 485 citations · Full text

, , +15

Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441

Yan Zhao, Huw D. Thomas, Michael A. Batey et al. · Cancer Research · 2006 · 447 citations · Full text

, , +16

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

Neil Johnson, Yuchen Li, Zandra E. Walton et al. · Nature Medicine · 2011 · 306 citations

, , +15

Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial

Huw D. Thomas, Christopher Calabrese, Michael A. Batey et al. · Molecular Cancer Therapeutics · 2007 · 302 citations

, , +15

1–5 of 58